1. Lemmon MA, Schlessinger J: Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci 1994, 19:459–463.
2. Salomon D, Brandt R, Ciardiello F, et al.: Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995, 19:183–232.
3. Rusch V, Klimstra D, Venkatraman E, et al.: Overexpression of the EGFR and its ligand, TGF alpha, is frequent in resectable non-small cell lung cancer, but does not predict tumor progression. Clin Cancer Res 1997, 3:515–522.
4. Rusch V, Baselga J, Cordon-Cardo C, et al.: Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 1993, 53:2379–2385.
5. Rusch V, Klimstra D, Linkov I, et al.: Aberrant expression of p53 or EGFR is frequent in early bronchial preneoplasia and coexpression precedes development of squamous cell carcinoma. Cancer Res 1995, 55:1365–1372.